Manufacturing, Recombinant Proteins

Wuxi Biologics to Install Large-Scale Single-Use Bioreactor

March 22, 2018

The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.

Shire, AB Biosciences Enter Autoimmune Disease Agreement

February 02, 2018

Shire will receive exclusive license to develop and commercialize AB Biosciences' pan receptor interacting molecule program for autoimmune and inflammatory diseases.

Univercells to Develop Antibody Production Platform with $2.9-Million Grant

January 23, 2018

The funding from the Walloon Region will enable Univercells to start developing a manufacturing platform aimed at driving down costs of biosimilars manufacturing.

Sartorius Stedim Biotech to Equip Abzena Single-Use Manufacturing Sites

January 11, 2018

Sartorius Stedim Biotech will equip Abzena’s contract development and manufacturing facilities in Bristol, PA, and San Diego, CA, with single-use equipment and scale-up technologies.

Wuxi Griffin Opens a New Aseptic Fill Finish Facility

January 04, 2018

The contract manufacturing company has completed construction on a new aseptic fill/finish facility in Wuxi, China.

WuXi Biologics Starts Up Large-Scale, Single-Use Biomanufacturing Facility

December 08, 2017

The new 30,000-L, $150-million biologics manufacturing facility in Wuxi, China, quintuples the company’s existing manufacturing capability.

GE Healthcare Completes Acquisition of Bioprocessing Start-Up

November 28, 2017

The acquisition gives GE Healthcare access to a nanofiber-based platform purification technology that can offer improvements in biopharmaceutical productivity.

Pall Debuts New Inline Diafiltration Modules for Continuous Bioprocessing

November 16, 2017

The company’s new modules offer scalable single-pass diafiltration and were exclusively showcased during its Leadership Forum series in Westborough, MA.

Kraig Biocraft to Develop Recombinant Spider Silk for US Army

October 30, 2017

The biotechnology company has entered a contract with the United States Army to develop custom recombinant spider silk for protective textile applications.

iBio and Aethlon Medical Announce Manufacturing Collaboration

October 16, 2017

The companies will collaborate to produce and improve the recombinant properties of Aethlon’s Hemopurifier blood purification device.